These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11411770)

  • 1. Role of endothelin-1 in hypertension and vascular disease.
    Schiffrin EL
    Am J Hypertens; 2001 Jun; 14(6 Pt 2):83S-89S. PubMed ID: 11411770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin: role in hypertension.
    Schiffrin EL
    Biol Res; 1998; 31(3):199-208. PubMed ID: 9830507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-of-the-Art lecture. Role of endothelin-1 in hypertension.
    Schiffrin EL
    Hypertension; 1999 Oct; 34(4 Pt 2):876-81. PubMed ID: 10523377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin and endothelin antagonists in hypertension.
    Schiffrin EL
    J Hypertens; 1998 Dec; 16(12 Pt 2):1891-5. PubMed ID: 9886874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin: role in experimental hypertension.
    Schiffrin EL
    J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S33-35. PubMed ID: 10976778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 gene expression in blood vessels and kidney of spontaneously hypertensive rats (SHR), L-NAME-treated SHR, and renovascular hypertensive rats.
    Deng LY; Schiffrin EL
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S380-3. PubMed ID: 9595489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelin in hypertension.
    Schiffrin EL
    Vascul Pharmacol; 2005 Jun; 43(1):19-29. PubMed ID: 15955745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats.
    Schiffrin EL; Lariviere R; Li JS; Sventek P; Touyz RM
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S188-90. PubMed ID: 9072349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular and cardiac overexpression of endothelin-1 gene in one-kidney, one clip Goldblatt hypertensive rats but only in the late phase of two-kidney one clip Goldblatt hypertension.
    Sventek P; Turgeon A; García R; Schiffrin EL
    J Hypertens; 1996 Jan; 14(1):57-64. PubMed ID: 12013496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
    Schiffrin EL; Larivière R; Li JS; Sventek P
    J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelin-1 expression and effect of an endothelin ETA antagonist on structure and function of small arteries from stroke-prone spontaneously hypertensive rats.
    Sharifi AM; He G; Touyz RM; Schiffrin EL
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S309-12. PubMed ID: 9595467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats.
    Li JS; Schürch W; Schiffrin EL
    Am J Hypertens; 1996 Aug; 9(8):803-11. PubMed ID: 8862227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endothelin-1 in hypertension.
    Iglarz M; Schiffrin EL
    Curr Hypertens Rep; 2003 Apr; 5(2):144-8. PubMed ID: 12642014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
    Giulumian AD; Pollock DM; Clarke N; Fuchs LC
    Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of endothelin-1 in deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.
    Matsumura Y; Fujita K; Miyazaki Y; Takaoka M; Morimoto S
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S456-8. PubMed ID: 8587444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
    Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of endothelin in cardiovascular disease.
    Schiffrin EL; Intengan HD; Thibault G; Touyz RM
    Curr Opin Cardiol; 1997 Jul; 12(4):354-67. PubMed ID: 9263647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
    Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.